Bionano Genomics, Inc. Long-Term Debt
Bionano Genomics, Inc. (BNGO) had Long-Term Debt of $0 as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2022-03-01
- 2021-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2021-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2021-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2021-03-31: Long-term Debt, Excluding Current Maturities $14.87M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $14.87M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $16.32M 10-K · filed 2022-03-01 | $16.33M 10-K · filed 2021-03-23 |
| 2020-09-30 | $1.77M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.77M 10-Q · filed 2020-08-13 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-23 | |
| 2019-09-30 | $18.78M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $18.62M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $18.38M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.03M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $9.01M 10-Q · filed 2018-11-07 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |